More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-07-24-09-51-58-648-6a6335be20291f5022b83109.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-01-29-10-58-05-125-697b3d3d0371dbadd5829221.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-07-14-13-18-49-287-6a563739af1c9be4bc219fe1.jpg)